n-(1-methyl-2-phenylethyl)adenosine has been researched along with Liver Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casado, FJ; Casadó, V; Duflot, S; Fernández-Veledo, S; Franco, R; Lluís, C; Norman, RI; Pastor-Anglada, M; Riera, B | 1 |
1 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and Liver Neoplasms
Article | Year |
---|---|
ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane; Glucose; Hepatocytes; Liver Neoplasms; Male; Membrane Transport Proteins; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Protein Isoforms; Protein Subunits; Purine Nucleosides; Rats; Rats, Wistar; Receptor, Adenosine A1 | 2004 |